MO ab initio study of the structural and electronic properties of the 5-lipoxygenase inhibitor zileuton

被引:1
|
作者
Ramusino, MC [1 ]
机构
[1] Ist Super Sanita, Lab Chim Farm, I-00161 Rome, Italy
来源
关键词
5-lipoxygenase inhibitor; ab initio study; conformational analysis; protonation processes; UV absorption spectrum;
D O I
10.1016/S0166-1280(97)00266-2
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The conformational space of zileuton was investigated by MO ab initio calculations at the HF/6-31G** level. The computed energies of the three most stable conformers were found to lie in a small range ( < 4.0 kcal/mol), indicating a certain degree of conformational flexibility. The preferred protonation site in vacuo and in water (simulated within the Onsager reaction field model) was characterised; the cation resulting from carbonyl oxygen protonation was predicted to be the most stable, both in vacuo and in water. The UV spectrum of zileuton was also recorded in different solvents and the experimental results were implemented by the outcome of a CI-Singles theoretical study of the excited state properties of the model compound benzothiophene, which is the chromophoric moiety of zileuton. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:237 / 242
页数:6
相关论文
共 50 条
  • [1] ZILEUTON - A 5-LIPOXYGENASE INHIBITOR IN RHEUMATOID-ARTHRITIS
    WEINBLATT, ME
    KREMER, JM
    COBLYN, JS
    HELFGOTT, S
    MAIER, AL
    PETRILLO, G
    HENSON, B
    RUBIN, P
    SPERLING, R
    JOURNAL OF RHEUMATOLOGY, 1992, 19 (10) : 1537 - 1541
  • [3] Zileuton: The first 5-lipoxygenase inhibitor for the treatment of asthma
    Wenzel, SE
    Kamada, AK
    ANNALS OF PHARMACOTHERAPY, 1996, 30 (7-8) : 858 - 864
  • [4] SYNTHESIS OF THE 5-LIPOXYGENASE INHIBITOR ZILEUTON FROM THIOPHENOL
    BASHA, A
    BROOKS, DW
    JOURNAL OF ORGANIC CHEMISTRY, 1993, 58 (05): : 1293 - 1294
  • [5] KINETICS AND MECHANISM OF DEGRADATION OF ZILEUTON, A POTENT 5-LIPOXYGENASE INHIBITOR
    ALVAREZ, FJ
    SLADE, RT
    PHARMACEUTICAL RESEARCH, 1992, 9 (11) : 1465 - 1473
  • [6] THE DISCOVERY AND DEVELOPMENT OF ZILEUTON - AN ORALLY ACTIVE 5-LIPOXYGENASE INHIBITOR
    BELL, RL
    YOUNG, PR
    ALBERT, D
    LANNI, C
    SUMMERS, JB
    BROOKS, DW
    RUBIN, P
    CARTER, GW
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1992, 14 (03): : 505 - 510
  • [7] SYNTHESIS OF CHIRAL ZILEUTON, A POTENT AND SELECTIVE INHIBITOR OF 5-LIPOXYGENASE
    HSIAO, CN
    KOLASA, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 203 : 442 - ORGN
  • [8] SYNTHESIS OF CHIRAL ZILEUTON, A POTENT AND SELECTIVE INHIBITOR OF 5-LIPOXYGENASE
    HSIAO, CN
    KOLASA, T
    TETRAHEDRON LETTERS, 1992, 33 (19) : 2629 - 2632
  • [9] Reduction of renal ischemia-reperfusion injury in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton
    Patel, NSA
    Cuzzocrea, S
    Chatterjee, PK
    Di Paola, R
    Sautebin, L
    Britti, D
    Thiemermann, C
    MOLECULAR PHARMACOLOGY, 2004, 66 (02) : 220 - 227
  • [10] 5-LIPOXYGENASE INHIBITORY ACTIVITY OF ZILEUTON
    CARTER, GW
    YOUNG, PR
    ALBERT, DH
    BOUSKA, J
    DYER, R
    BELL, RL
    SUMMERS, JB
    BROOKS, DW
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1991, 256 (03): : 929 - 937